Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Bradykinin agonist activity of a novel, potent oxytocin antagonist.

Pettibone DJ, Clineschmidt BV, Lis EV, Ransom RW, Totaro JA, Young GS, Bock MG, Freidinger RM, Veber DF, Williams PD.

Eur J Pharmacol. 1991 Apr 24;196(3):233-7.

PMID:
1893911
2.

In vitro pharmacological profile of a novel structural class of oxytocin antagonists.

Pettibone DJ, Clineschmidt BV, Lis EV, Reiss DR, Totaro JA, Woyden CJ, Bock MG, Freidinger RM, Tung RD, Veber DF, et al.

J Pharmacol Exp Ther. 1991 Jan;256(1):304-8.

PMID:
1988661
3.

Identification of functional oxytocin receptors in lactating rat mammary gland in vitro.

Pettibone DJ, Woyden CJ, Totaro JA.

Eur J Pharmacol. 1990 Apr 25;188(4-5):235-41.

PMID:
2163875
4.

[3H]L-657,743 (MK-912): a new, high affinity, selective radioligand for brain alpha 2-adrenoceptors.

Pettibone DJ, Flagg SD, Totaro JA, Clineschmidt BV, Huff JR, Young SD, Chen R.

Life Sci. 1989;44(7):459-67.

PMID:
2564617
5.

Heterogeneity of [3H]neurotensin bindings: studies with dynorphin, L-156,903 and levocabastine.

Pettibone DJ, Totaro JA, Harris E, Robinson FM.

Brain Res. 1988 Aug 9;457(2):212-8.

PMID:
2905916
6.

High affinity binding of [3H]neurotensin of rat uterus.

Pettibone DJ, Totaro JA.

Peptides. 1987 Nov-Dec;8(6):1169-72.

PMID:
2831520
7.

Binding of (+)PHNO and other D2-dopamine agonists to D1-dopamine receptors labelled by [3H]SCH 23390.

Pettibone DJ, Totaro JA, Clineschmidt BV.

J Neural Transm. 1987;69(1-2):147-51.

PMID:
2953862
8.
9.

Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants.

Pettibone DJ, Totaro JA, Pflueger AB.

Eur J Pharmacol. 1984 Jul 20;102(3-4):425-30.

PMID:
6489435
10.

Tetrabenazine-induced depletion of brain monoamines: mechanism by which desmethylimipramine protects cortical norepinephrine.

Pettibone DJ, Pflueger AB, Totaro JA.

Eur J Pharmacol. 1984 Jul 20;102(3-4):431-6.

PMID:
6149131
11.

Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivatives.

Remy DC, Britcher SF, King SW, Anderson PS, Hunt CA, Randall WC, BĂ©langer P, Atkinson JG, Girard Y, Rooney CS, Fuentes JJ, Totaro JA, Robinson JL, Risley EA, Williams M.

J Med Chem. 1983 Jul;26(7):974-80.

PMID:
6134835
12.

Preparation of some 10-[3-(dimethylamino)-1-propyl]-10H-pyrazino[2,3-b][1,4] benzothiazines as potential neuroleptics.

Saari WS, Cochran DW, Lee YC, Cresson EL, Springer JP, Williams M, Totaro JA, Yarbrough GG.

J Med Chem. 1983 Apr;26(4):564-9.

PMID:
6132009
14.

Interactions of taurine and beta-alanine with central nervous system neurotransmitter receptors.

Williams M, Risley EA, Totaro JA.

Life Sci. 1980 Feb 18;26(7):557-60. No abstract available.

PMID:
6245320
15.

Synthesis, assignment of absolute configuration, and receptor binding studies relevant to the neuroleptic activities of a series of chiral 3-substituted cyproheptadine atropisomers.

Randall WC, Anderson PS, Cresson EL, Hunt CA, Lyon TF, Rittle KE, Remy DC, Springer JP, Hirshfield JM, Hoogsteen K, Williams M, Risley EA, Totaro JA.

J Med Chem. 1979 Oct;22(10):1222-30. No abstract available.

PMID:
41950
16.
17.

Fenfluramine and brain serotonin.

Clineschmidt BV, Zacchei AG, Totaro JA, Pflueger AB, McGuffin JC, Wishousky TI.

Ann N Y Acad Sci. 1978 Jun 12;305:222-41. No abstract available.

PMID:
309298
18.

Interaction of 2-[beta-(4-hydroxyphenyl)ethylaminomethyl]tertralone (BE-2254: 'HEAT') with catecholamine receptors in rat brain membranes.

Williams M, Totaro JA, Clineschimidt BV.

J Pharm Pharmacol. 1978 Jun;30(6):390-1. No abstract available.

PMID:
26778
19.

A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212).

Clineschmidt BV, McGuffin JC, Pflueger AB, Totaro JA.

Br J Pharmacol. 1978 Apr;62(4):579-89.

20.

Inhibition of the serotoninergic uptake system by MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine)

Clineschmidt BV, Totaro JA, Pflueger AB, McGuffin JC.

Pharmacol Res Commun. 1978 Mar;10(3):219-28. No abstract available.

PMID:
684030
21.

Pharmacokinetics of methyldopa in man.

Kwan KC, Foltz EL, Breault GO, Baer JE, Totaro JA.

J Pharmacol Exp Ther. 1976 Aug;198(2):264-77.

PMID:
781212
22.

Fenfluramine: long-term reduction in brain serotonin (5-hydroxytryptamine).

Clineschmidt BV, Totaro JA, McGuffin JC, Pflueger AB.

Eur J Pharmacol. 1976 Jan;35(1):211-4.

PMID:
1253822
23.

Increased concentrations of 3-methoxy-4-hydroxyphenylethyl-eneglycol and homovanillic acid in rat brain after treatment with BE-2254 ("HEAT").

Clineschmidt BV, Totaro JA, Pflueger AB, McGuffin JC.

J Pharm Pharmacol. 1975 Oct;27(10):780-2. No abstract available.

PMID:
241795
24.

Fenfluramine-induced enhancement of confinement motor activity: an indirect 5-hydroxytryptamine-like action?

Clineschmidt BV, McGuffin JC, Pflueger AB, Totaro JA.

Neuropharmacology. 1975 Apr;14(4):301-11. No abstract available.

PMID:
124023
25.

Displacement of norepinephrine from the rat heart by 14C-metaraminol.

Porter CC, Torchiana ML, Totaro JA, Stone CA.

Biochem Pharmacol. 1967 Nov;16(11):2117-24. No abstract available.

PMID:
6076605
26.

The effect of the optical isomers of alpha-methyl-p-tyrosine upon brain and heart catecholamines in the mouse.

Porter CC, Totaro JA, Burcin A, Wynosky ER.

Biochem Pharmacol. 1966 May;15(5):583-90. No abstract available.

PMID:
5961435
27.
28.

ANTAGONISM OF CERTAIN EFFECTS OF CATECHOLAMINE-DEPLETING AGENTS BY ANTIDEPRESSANT AND RELATED DRUGS.

STONE CA, PORTER CC, STAVORSKI JM, LUDDEN CT, TOTARO JA.

J Pharmacol Exp Ther. 1964 May;144:196-204. No abstract available.

PMID:
14183431
29.

COMPARISON OF SOME PHARMACOLOGIC EFFECTS OF CERTAIN 6-SUBSTITUTED DOPAMINE DERIVATIVES WITH RESERPINE, GUANETHIDINE AND METARAMINOL.

STONE CA, STAVORSKI JM, LUDDEN CT, WENGER HC, ROSS CA, TOTARO JA, PORTER CC.

J Pharmacol Exp Ther. 1963 Nov;142:147-56. No abstract available.

PMID:
14079651
30.

Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice.

PORTER CC, TOTARO JA, STONE CA.

J Pharmacol Exp Ther. 1963 Jun;140:308-16. No abstract available.

PMID:
13972348
31.

Inhibition of DOPA decarboxylase by the hydrazino analog of alpha-methylDOPA.

PORTER CC, WATSON LS, TITUS DC, TOTARO JA, BYER SS.

Biochem Pharmacol. 1962 Nov;11:1067-77. No abstract available.

PMID:
13972347
32.

Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog.

STONE CA, ROSS CA, WENGER HC, LUDDEN CT, BLESSING JA, TOTARO JA, PORTER CC.

J Pharmacol Exp Ther. 1962 Apr;136:80-8. No abstract available.

PMID:
13917453
33.

Some biochemical effects of alpha-methyl-3,4-dihydroxyphenylalanine and related compounds in mice.

PORTER CC, TOTARO JA, LEIBY CM.

J Pharmacol Exp Ther. 1961 Nov;134:139-45. No abstract available.

PMID:
14488062

Supplemental Content

Loading ...
Support Center